"...issued a weaker-than-expected quarterly sales report... "
I want to know who was doing all this expecting and how much better growth did they expect?
A 20% drop in SP suggests that perhaps they were expecting a 40% better return?
Still, YOY, not bad for a novel drug in an experimental field from a company that has been tarred with dirty tactics and manipulation throughout it's development and approval.
follow the right path for success, page-10
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $465.4M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 31.8¢ | $845.3K | 2.621M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 140318 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 14222 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |